Reclassification of Severe Ischemia on PET Versus SPECT MPI Using a Same-Patient Simultaneous Imaging Protocol

Femina S. Patel; Timothy M. Bateman; John A. Spertus; A. Iain McGhie; Staci A. Courter; James A. Case; Gary V. Heller; Krishna K. Patel

doi:10.1016/j.jcmg.2021.12.004

Reclassification of Severe Ischemia on PET Versus SPECT MPI Using a Same-Patient Simultaneous Imaging Protocol

Femina S. Patel, Timothy M. Bateman, John A. Spertus, A. Iain McGhie, Staci A. Courter, James A. Case, Gary V. Heller, Krishna K. Patel

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1158-1159
Number of pages	2
Journal	JACC: Cardiovascular Imaging
Volume	15
Issue number	6
DOIs	https://doi.org/10.1016/j.jcmg.2021.12.004
State	Published - Jun 2022

Access to Document

10.1016/j.jcmg.2021.12.004

Cite this

@article{d9c2f359283442e092152758ad29da23,

title = "Reclassification of Severe Ischemia on PET Versus SPECT MPI Using a Same-Patient Simultaneous Imaging Protocol",

author = "Patel, {Femina S.} and Bateman, {Timothy M.} and Spertus, {John A.} and McGhie, {A. Iain} and Courter, {Staci A.} and Case, {James A.} and Heller, {Gary V.} and Patel, {Krishna K.}",

note = "Funding Information: This study was funded by Blue Cross Blue Shield of Kansas City. The funding organization had no role in the conduct or reporting of the study. Dr Bateman has served as a consultant to AIM, AstraZeneca, Curium, and GE Healthcare; has received research grants from Bracco, GE Healthcare, and Jubilant DraxImage; has an equity interest in Cardiovascular Imaging Technologies; and holds intellectual property rights for Imagen SPECT and PET software. Dr Spertus has served as a consultant to United Healthcare, Bayer, Janssen, Amgen, Merck, Myokardia, and Novartis; has received research grants from Abbott Vascular, and Novartis; is the principal investigator of an analytic center for the American College of Cardiology; and owns the copyrights to the SAQ, KCCQ, and PAQ. Dr Case has served as a consultant to AstraZeneca and GE Healthcare; has received research grants from Bracco, GE Healthcare, and Jubilant DraxImage; has an equity interest in Cardiovascular Imaging Technologies; and holds intellectual property rights for Imagen SPECT and PET software. Dr Heller has served as a medical advisor to Molecular Imaging Services; and has served on the scientific advisory board of GE Healthcare. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: This study was funded by Blue Cross Blue Shield of Kansas City. The funding organization had no role in the conduct or reporting of the study. Dr Bateman has served as a consultant to AIM, AstraZeneca, Curium, and GE Healthcare; has received research grants from Bracco, GE Healthcare, and Jubilant DraxImage; has an equity interest in Cardiovascular Imaging Technologies; and holds intellectual property rights for Imagen SPECT and PET software. Dr Spertus has served as a consultant to United Healthcare, Bayer, Janssen, Amgen, Merck, Myokardia, and Novartis; has received research grants from Abbott Vascular, and Novartis; is the principal investigator of an analytic center for the American College of Cardiology; and owns the copyrights to the SAQ, KCCQ, and PAQ. Dr Case has served as a consultant to AstraZeneca and GE Healthcare; has received research grants from Bracco, GE Healthcare, and Jubilant DraxImage; has an equity interest in Cardiovascular Imaging Technologies; and holds intellectual property rights for Imagen SPECT and PET software. Dr Heller has served as a medical advisor to Molecular Imaging Services; and has served on the scientific advisory board of GE Healthcare. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",

year = "2022",

month = jun,

doi = "10.1016/j.jcmg.2021.12.004",

language = "English",

volume = "15",

pages = "1158--1159",

journal = "JACC: Cardiovascular Imaging",

issn = "1936-878X",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Reclassification of Severe Ischemia on PET Versus SPECT MPI Using a Same-Patient Simultaneous Imaging Protocol

AU - Patel, Femina S.

AU - Bateman, Timothy M.

AU - Spertus, John A.

AU - McGhie, A. Iain

AU - Courter, Staci A.

AU - Case, James A.

AU - Heller, Gary V.

AU - Patel, Krishna K.

N1 - Funding Information: This study was funded by Blue Cross Blue Shield of Kansas City. The funding organization had no role in the conduct or reporting of the study. Dr Bateman has served as a consultant to AIM, AstraZeneca, Curium, and GE Healthcare; has received research grants from Bracco, GE Healthcare, and Jubilant DraxImage; has an equity interest in Cardiovascular Imaging Technologies; and holds intellectual property rights for Imagen SPECT and PET software. Dr Spertus has served as a consultant to United Healthcare, Bayer, Janssen, Amgen, Merck, Myokardia, and Novartis; has received research grants from Abbott Vascular, and Novartis; is the principal investigator of an analytic center for the American College of Cardiology; and owns the copyrights to the SAQ, KCCQ, and PAQ. Dr Case has served as a consultant to AstraZeneca and GE Healthcare; has received research grants from Bracco, GE Healthcare, and Jubilant DraxImage; has an equity interest in Cardiovascular Imaging Technologies; and holds intellectual property rights for Imagen SPECT and PET software. Dr Heller has served as a medical advisor to Molecular Imaging Services; and has served on the scientific advisory board of GE Healthcare. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: This study was funded by Blue Cross Blue Shield of Kansas City. The funding organization had no role in the conduct or reporting of the study. Dr Bateman has served as a consultant to AIM, AstraZeneca, Curium, and GE Healthcare; has received research grants from Bracco, GE Healthcare, and Jubilant DraxImage; has an equity interest in Cardiovascular Imaging Technologies; and holds intellectual property rights for Imagen SPECT and PET software. Dr Spertus has served as a consultant to United Healthcare, Bayer, Janssen, Amgen, Merck, Myokardia, and Novartis; has received research grants from Abbott Vascular, and Novartis; is the principal investigator of an analytic center for the American College of Cardiology; and owns the copyrights to the SAQ, KCCQ, and PAQ. Dr Case has served as a consultant to AstraZeneca and GE Healthcare; has received research grants from Bracco, GE Healthcare, and Jubilant DraxImage; has an equity interest in Cardiovascular Imaging Technologies; and holds intellectual property rights for Imagen SPECT and PET software. Dr Heller has served as a medical advisor to Molecular Imaging Services; and has served on the scientific advisory board of GE Healthcare. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2022/6

Y1 - 2022/6

UR - http://www.scopus.com/inward/record.url?scp=85131144172&partnerID=8YFLogxK

U2 - 10.1016/j.jcmg.2021.12.004

DO - 10.1016/j.jcmg.2021.12.004

M3 - Letter

C2 - 35680222

AN - SCOPUS:85131144172

VL - 15

SP - 1158

EP - 1159

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

SN - 1936-878X

IS - 6

ER -